Cargando…
The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients
Modern advances in technology such as next-generation sequencing and digital PCR make detection of minor circulating cell-free tumor DNA amounts in blood from cancer patients possible. Samples can be obtained minimal-invasively, tested for treatment-determining genetic alterations and are considered...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080785/ https://www.ncbi.nlm.nih.gov/pubmed/32188904 http://dx.doi.org/10.1038/s41598-020-61818-1 |